Rob Goodwin

Rob Goodwin is the Chief Operating Officer at Parexel, assuming this role in September 2025, where responsibilities include overseeing core clinical functions and driving innovation in clinical trial data methodologies. Prior experience at Pfizer, from October 2010 to August 2025, encompasses roles as Senior Vice President of Clinical Development and Operations, and Vice President in various capacities, focusing on clinical trial management and operational excellence. Educational qualifications include an MBA in Pharmaceutical and Chemical Studies from Fairleigh Dickinson University and an MS in Research Measurement and Quantitative Analysis from Southern Connecticut State University.